2021年8月2日 · In patients with VTE diagnosed in the absence of transient risk factor (unprovoked VTE or provoked by a persistent risk factor) who cannot receive a DOAC, we suggest offering extended-phase anticoagulation with a VKA (weak recommendation, moderate-certainty evidence).

Results: The panel generated 29 guidance statements, 13 of which are graded as strong recommendations, covering aspects of antithrombotic management of VTE from initial management through secondary prevention and risk reduction of postthrombotic syndrome. Four new guidance statements have been added that did not appear in the 9th edition (2012 ...

2024年3月5日 · Statement 11.0 (2021): In patients with an acute VTE (DVT of the leg or PE) we recommend apixaban, dabigatran, edoxaban, or rivaroxaban over VKA as treatment phase (first 3 months) anticoagulant therapy (Strong Recommendation, Moderate-Certainty Evidence). (Strong Statement “We Recommend” in Favor of the Intervention.)

2022年4月29日 · 2021 年底，美国胸科医师学会（ACCP）发布了静脉血栓栓塞症（VTE）的抗栓治疗：CHEST 指南第二次更新。 该指南于 2012 年发表第九版（简称 AT9），于 2016 年进行第一次更新（曾经简称 AT10），此次对 AT9 进行了第二次更新。 CHEST 指南的特点在于： 是 VTE 指南，既包含肺栓塞又包含 DVT（深静脉血栓）集中讨论治疗问题，不包括诊断。 相比较而言，2019 年 ESC/ERS 指南讨论的是急性肺栓塞，并且包括了诊断和治疗。 本次指南更新， …

静脉血栓栓塞症（venous thromboembolism, VTE)是创伤骨科患者的常见并发症，也是导致患者围手术期死亡的主要原因之一。 对创伤患者施以有效的预防措施，可以降低VTE的发生风险，减轻患者痛苦，减少医疗费用。

2021年12月1日 · In patients with VTE diagnosed in the absence of transient provocation (unprovoked VTE or provoked by persistent risk factor), we recommend offering extended-phase anticoagulation with a DOAC (strong recommendation, moderate-certainty evidence).

更多相关文档 . 2021年accp静脉血栓栓塞抗栓治疗指南 星级： 46 页 重度静脉血栓栓塞症(vte)的治疗指南 星级： 44 页 2016accp指南：静脉血栓栓塞症抗血栓治疗

2021年，美国胸科医师学会(accp)对静脉血栓栓塞（vte）的抗栓治疗指南进行2次更新，本文就17个pico问题提出了指导建议。 中文标题： 2021 CHEST指南：静脉血栓栓塞（VTE）的抗栓治疗（第2次更新）

2021年8月3日 · The American College of Chest Physicians (CHEST) recently released new clinical guidelines for venous thromboembolism (VTE) management, “Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel” that provides 29 recommendations on 17 Patients, Interventions, Comparators, Outcomes (PICO) questions, four ...

2021年7月3日 · Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong provoking risk factors for venous thromboembolism include major surgery and active cancer, but most events are unprovoked.